AstraZeneca mulls spinning off China activities

Anglo-Swedish drugmaker AstraZeneca could spin off its Chinese division and list it in Hong Kong to minimise China-related risks, the Financial Times reported on Monday.

The company started discussions several months ago, the business daily said citing people familiar with the talks.

AstraZeneca declined to comment.

According to the FT, the drugmaker was seeking to diminish the risk of any potential Chinese crackdown on foreign companies. — Agence France-Presse

Subscribe to

Stay in the know with Bilyonaryo’s unparalleled coverage of business news and global industries!

Elevate your understanding of the Philippine business landscape and gain insights into worldwide markets by subscribing to our dedicated channels. Receive breaking news, in-depth analyses, and exclusive interviews with industry leaders directly on Viber, WhatsApp, and Facebook. Stay informed and empowered with our Email Newsletter, delivering curated content right to your inbox.

Don’t miss out on crucial updates and trends shaping economies and businesses both locally and internationally.

Join Bilyonaryo’s community today by clicking the button below to subscribe and stay ahead in the dynamic world of business.

Share this Bilyonaryo story